Table 4.
Comparison of clinical features at presentation between different studies of DLBCL associated with HCV25-28
NR indicates not reported; OS, overall survival; RFS, relapse-free survival; EFS, event-free survival; and PFS, progression-free survival.
*The working formulation was used to define histology by Tomita et al,27 reporting 20 large cell lymphomas and other aggressive histologies; this study included also 4 cases of T-cell origin.
